SCI Abstract

search
+
Cytology-negative, non-myoinvasive stage IC serous endometrial cancer: Assessment of adjuvant chemotherapy omission
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Prognostic indicators of recurrence and treatment-free interval in uterine carcinosarcoma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
A phase II trial of palbociclib plus letrozole after progression on second-line chemotherapy for women with hormone receptor-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer (LACOG 1018)
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
No increase in chronic kidney disease after postoperative acute kidney injury in gynecologic oncologic ERAS surgery
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Optimizing therapy for cervical cancers – Translating trial data into clinical decision-making
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Fertility sparing surgery in patients with advanced borderline ovarian tumors: Oncologic outcomes of a single-institution cohort
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
An exploratory analysis of driver gene alterations and their potential prognostic relevance in endometrial cancer with POLE exonuclease domain mutations
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
GTN misdiagnosed as ectopic pregnancy: a 17-year retrospective cohort study
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
REACT bowel REcovery after CyToreductive surgery for advanced ovarian cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Adjuvant radiotherapy outcomes and prognostic factors in FIGO 2023 stage IIC endometrial cancer: One sea, different depths
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Missed opportunities: Germline testing following tumor sequencing
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Association between glucagon-like peptide-1 receptor agonists and ovarian cancer survival: A population-based cohort study
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Datopotamab deruxtecan, a novel TROP2-tareting antibody-drug conjugate with a topoisomerase I inhibitor payload, shows preclinical activity against primary and metastatic uterine and ovarian TROP2 over-expressing carcinosarcoma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Delays, fragmentation, and desire for alternatives: A qualitative study of the patient experience through diagnosis and treatment of endometrial cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
What are we worth? An SGO analysis of compensation structures that measure and value work in academic gynecologic oncology practices
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 95a02...
Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations
Update your browser to view ScienceDirect. ...
Biobehavioral predictors of mood, pain, fatigue, and insomnia in endometrial cancer survivors
Update your browser to view ScienceDirect. ...
LGBTQIA+ populations still neglected in trials and their health needs
Update your browser to view ScienceDirect. ...
Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis
Update your browser to view ScienceDirect. ...
Adjuvant therapy de-escalation for stage I uterine leiomyosarcoma: A systematic review and meta-analysis
Update your browser to view ScienceDirect. ...
Standard of care treatment for stage IVB cervical cancer: A systematic review and meta-analysis
Update your browser to view ScienceDirect. ...
Insurance coverage and access to gynecologic oncology: Where are we now
Update your browser to view ScienceDirect. ...
What happens after menopause? (WHAM): Impact of risk-reducing salpingo-oophorectomy on depressive and anxiety symptoms at 24 months
Update your browser to view ScienceDirect. ...
Evolutionary pathways in early-stage, non-myoinvasive endometrioid endometrial cancers of no specific molecular profile
Update your browser to view ScienceDirect. ...
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer
Update your browser to view ScienceDirect. ...
Load More
format_indent_increase